Compare ImmunityBio Inc. Common Stock (IBRX) vs Principal Financial Group Inc Common Stock (PFG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Principal Financial Group Inc Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.51 (market cap $10.51B), while Principal Financial Group Inc Common Stock trades at $107.24 (market cap $23.51B). The key difference: Principal Financial Group Inc Common Stock is far larger — about 2.2× ImmunityBio Inc. Common Stock's market cap, and Principal Financial Group Inc Common Stock pays a 3.06% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Principal Financial Group Inc Common Stock for 1 Days on average.
| IBRX | PFG | |
|---|---|---|
Market Cap | $10.51B | $23.51B |
Volume | 10,445,785 | 1,118,505 |
Sector | Health | Financials |
52-Week High | $11.55 | $118.51 |
52-Week Low | $1.98 | $78.39 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $22.59B |
Dividend Yield | — | 3.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Principal Financial Group Inc Common Stock
Principal Financial Group provides retirement, insurance, and asset management services. It serves individuals, employers, and institutional clients.
Read more on PFG →
